Advertisement
Organisation › Details
Biom’Up S.A. (Euronext: BUP)
Headquartered in France, Biom’Up designs hemostatic products based on patented biopolymers that aim to simplify surgical procedures in numerous specialties (spine, cardiothoracic, general, orthopedic, plastic). Its flagship product, HEMOBLAST™ Bellows, is a unique hemostatic solution, ready to use and is usable once or several times during the surgery. Developed by a world-renowned scientific team, HEMOBLAST™ Bellows has obtained positive results for all the primary and secondary endpoints of Phase III of its pivotal study involving 412 patients in the United States. A PMA (Pre-Market Approval) application for HEMOBLAST™ Bellows was submitted to the FDA (Food & Drug Administration) in July 2017 with a view to obtaining marketing approval in the United States in mid-2018. Since its creation, Biom’Up has benefited from the support of prominent European investors such as Bpifrance, Innobio, GIMV, Lundbeckfond, Mérieux Participation, SHAM and ACG. *
Start | 0105-01-01 established | |
Industry | biomaterials | |
Industry 2 | medical device | |
Person | Binant, Étienne (Biom’Up 201509 CEO) | |
Person 2 | Forest, Patricia (Biom’Up SA 201310 Deputy CEO + Scientific Director) | |
Region | Lyon | |
Country | France | |
Street | 8 allée Irène Joliot Curie Parc Technologique de Lyon | |
City | 69800 Saint-Priest | |
Tel | +33-4-8657-3610 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | B: 11 to 50 (2013-10-25) |
Currency | EUR | |
Annual sales | 3,000,000 (turnover (2014) 2014-12-31) | |
* Document for »About Section«: Bryan, Garnier & Co., Ltd.. (10/11/17). "Press Release: Bryan Garnier & Co Acts as Sole Global Coordinator for Biom'Up's Landmark Euronext IPO, Raising up to €44 Million including Greenshoe". | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Biom’Up S.A. (Euronext: BUP)
- [1] Euronext N.V.. (10/13/17). "Press Release: Biom’up Lists on Euronext Paris to Finance Its Development". Paris....
- [2] Bryan, Garnier & Co., Ltd.. (10/11/17). "Press Release: Bryan Garnier & Co Acts as Sole Global Coordinator for Biom'Up's Landmark Euronext IPO, Raising up to €44 Million including Greenshoe"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top